Tag: CBT > FDA Policy on CBD: Page 2

Legislation and Regulation

UPDATED: President Biden Signs Bipartisan Cannabis Research Bill

The legislation cleared its final congressional hurdle with a voice vote last month in the Senate, paving way for researchers to fully study the impacts of cannabis use.

December 2, 2022

Legislation and Regulation

FDA Warns Five Companies for Illegally Selling CBD Food and Beverage Products

The U.S. Food and Drug Administration issued warning letters to five companies that the agency claims are selling products that consumers may confuse for traditional foods and beverages.

November 22, 2022

Kentucky

Hemp Applications Open in Kentucky for 2023

Individuals applying for a cultivation license or renewing their license must apply by March 15, 2023.

November 18, 2022

Legislation and Regulation

National Industrial Hemp Council Urges FDA to Approve Hemp Seed for Animal Feed

The NIHC sent a letter to the FDA, calling for the federal agency to approve hemp seed as a viable feed alternative for livestock producers.

November 7, 2022

Legislation and Regulation

FDA’s Most Recent Hire Could Lead to CBD Regulation

The federal agency named Norman Birenbaum as senior public health advisor at the agency’s Center for Regulatory Programs Sept. 26.

September 28, 2022

Idaho

Idaho to Ban Hemp, CBD Products Intended for Animal Use

The policy will take effect Nov 1.

September 21, 2022

Legislation and Regulation

Where is the FDA on CBD?

If the agency began regulating the cannabinoid, per industry members, products would be safer and the market would be more successful.

August 24, 2022

Compliance

Study Finds Topical CBD Products Are Often Inaccurately Labeled

John Hopkins Medicine tested 105 topical CBD products and found that less than a fourth were labeled correctly.

July 25, 2022

Future of Hemp Industry

Brightfield Group Estimates US CBD Market Growth Rate Greatly Dependent on FDA Guidance

The report states that FDA officials’ decision on whether to regulate CBD will determine the market’s overall growth rate and its presence in various distribution channels.

July 20, 2022

SAFE Banking Act

‘The Clash Between State and Federal Law in the Cannabis Industry’: 4 Key Takeaways on Federal Policy Reform Efforts

Cozen O’Connor attorneys share insight on where cannabis policy reform might be headed to address the disconnect between federal prohibition and state-legal programs.

June 24, 2022

Compliance

FDA Warns Four Companies for Selling Unapproved Animal Drugs That Contain CBD

The agency said in its warning letters that the drugs, which are intended for use in food-producing animals, violate the Federal Food, Drug, and Cosmetic Act.

May 27, 2022

Hemp Research

New Study Addresses FDA's Concerns, Demonstrates CBD's Safety Profile

The study found that oral consumption of CBD does not negatively impact the liver or cause male reproductive toxicity and drowsiness.

May 19, 2022